These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6574295)

  • 1. Possible differentiation of human acute myeloblastic leukemia cells by daily and intermittent administration of aclacinomycin-A.
    Sakurai M; Sampi K; Hozumi M
    Leuk Res; 1983; 7(2):139-43. PubMed ID: 6574295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible differentiation treatment with aclacinomycin A in acute myelomonocytic leukemia refractory to conventional chemotherapy.
    Sato S; Sakashita A; Ishiyama T; Nakamaki T; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
    Anticancer Res; 1992; 12(2):371-6. PubMed ID: 1580553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic results with aclacinomycin A in recurring acute leukemias].
    Mitrou PS
    Onkologie; 1983 Aug; 6(4):192-4. PubMed ID: 6355949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory acute leukemia with aclacinomycin-A.
    Takahashi I; Hara M; Adachi T; Takaoka K; Sakano M; Lai M; Kohi F; Yorimitsu S; Tokioka M; Kitajima K; Kimura I; Sanada H
    Acta Med Okayama; 1980 Nov; 34(5):349-54. PubMed ID: 6449134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
    Steinheider G; Westendorf J; Marquardt H
    Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias.
    Mitrou PS; Kuse R; Anger H; Herrmann R; Bonfert B; Pralle H; Thiel E; Westerhausen M; Mainzer K; Bartels H
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):919-23. PubMed ID: 3862584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation of human promyelocytic leukemic cells (HL-60) induced by aclacinomycin-B].
    Lu Y; Han J; Liu HY; Zhong GP; Yang S; Jia TZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Jun; 8(3):211-3. PubMed ID: 2946461
    [No Abstract]   [Full Text] [Related]  

  • 9. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
    Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H; Boulé D; Trincal G; Fourcade A; Lampidis TJ
    Leuk Res; 1988; 12(5):411-8. PubMed ID: 3164087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
    Morin MJ; Sartorelli AC
    Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor efficacies of aclacinomycin A by oral administration.
    Tsukagoshi S; Tsuruo T; Yamori T; Iida H; Naganuma K; Sakurai Y
    J Pharmacobiodyn; 1980 Oct; 3(10):532-6. PubMed ID: 6937651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Oncology; 1986; 43(1):18-22. PubMed ID: 3455751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Dorval T; Ribaud P
    Biomed Pharmacother; 1984; 38(7):328-31. PubMed ID: 6596962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
    Casper ES; Gralla RJ; Young CW
    Cancer Res; 1981 Jun; 41(6):2417-20. PubMed ID: 6940656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin).
    Kerr IG; Archer S; DeAngelis C; Farrell S; Hanna S; McKee J
    Invest New Drugs; 1987; 5(2):171-6. PubMed ID: 3477533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.